León GWL, Kénol Saint–Surín, Rodríguez LH, Romaguera BD, Rodríguez FZ

Language: Spanish
References: 18
Page: 328-336
PDF size: 183.89 Kb.

ABSTRACT

A descriptive study of 60 operated and discharged patients with diagnosis of primary cancer of the hepatobiliopancreatic segment, assisted in the General Surgery Service of "Saturnino Lora Torres" Teaching Provincial Clinical Surgical Hospital in Santiago de Cuba was carried out in the period 2005-2011, exposed to an scheme of postoperative follow-up, with the objective of identifying the factors related to the survival for 5 years. The global survival was 17.6%, although it was higher for the gallbladder neoplasias and pancreas, associated with the diagnosis in the stages I and II, to the healing surgery and to the auxiliary treatment with cytostatic. It is concludes that the low survival of these patients is determined by the late diagnosis of the morbid process, so that a better interrelation is imperative between the primary and secondary levels of care, as well as to establish work groups for the development of surgery of the hepatobiliopancreatic segment in each hospital, so that they allow the uniform protocol of the behaviour to be followed.

REFERENCES

1. Rebasa P. Conceptos básicos del análisis de supervivencia. Cir Esp. 2005;78:222-30.

2. Arribalzaga EB. Interpretación de las curvas de supervivencia. Rev Chilena Cir. 2007 [citado 23 Jul 2011];59(1).

3. Turrini F, Viret F, Moureau L, Guiramand J, Moutardier B, Lelong M, et al. Neoadjuvant chemoradiation and pancreaticoduodenectomy for initially locally advanced head pancreatic adenocarcinoma. Eur J Surg Oncol. 2009;35:1306-11.

4. American Cancer Society. Cáncer de hígado [citado 7 Dic 2011].

5. Morris-Stiff G, Alabraba E, Tan YM, Shapey I, Bhati C, Tanniere P, et al. Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology. Eur J Surg Oncol. 2009;35:746-50.

6. Robles R, Parrilla P, Ramírez P, Sánchez-Bueno F, Marín C, Pastor P, et al. El trasplante hepático aumenta la resecabilidad R0 y la supervivencia de los pacientes con tumor de Klatskin irresecable no diseminado. Cir Esp. 2010; 87(2):82–8.

7. Hoyos S, Guzmán C. Resultados de la duodenopancreatectomia cefálica en el Hospital Pablo Tobón Uribe de Medellín en un período de tres años. Rev Colombiana Cir. 2008;23(1):12-5.

8. Deichler F, Fuentes M, Cárcamo C, Mariangel P. Tumores periampulares. Hallazgos y resultados en 21 casos consecutivos resecados. Cuad Cir (Valdivia). 2006; 20(1): 21-7.

9. Arroyo GF. Cáncer de vesícula biliar. Oncol Clin. 2003;8(1): 831-7.

10. Ramos Gallardo G. Factores pronósticos en cáncer de vesícula. Rev Invest Clin. 2005; 57(5):662-5.

11. Castillo García JJ, Ruiz Lizárraga J, Escrivá Machado JF, Córdova Pluma VH. Cáncer de vesícula biliar como hallazgo histopatológico posterior a la colecistectomía. Prevalencia e incidencia en el Hospital “Ángeles Pedregal”. Acta Méd Grupo Ángeles. 2010 [citado 7 Dic 2011]; 8(3).

12. Sabater L, Calvete J. Neoplasias de páncreas y periampulares: morbimortalidad, resultados funcionales y supervivencia a largo plazo. Cir Esp. 2009;86(3):159-66.

13. Argüello Arias PT. Expression of pancreatic cancer in the National Cancer Institute. Report of an institutional experience. Rev Col Gastroenterol. 2006; 21(3).

14. Goetze TO, Paolucci V. Benefits of reoperation of T2 and more advanced incidental gallbladder carcinoma: Analysis of the German registry. Ann Surg. 2008; 247:104–8.

15. Frena A, Marinillo P, La Guardia G, Martin F. Incidental gallbladder carcinoma. Chir Ital. 2007; 59:185–90.

16. Pawlik TM, Poon RT, Abdalla EK, Zorzi D, Ikai I, Curley SA, et al. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocelular carcinoma. Arch Surg. 2005 [citado 23 Jul 2011];140(5).

17. Seo DD, Lee HC, Jang MK, Min HJ, Kim KM, Lim YS, et al. Preoperative portal vein embolization and surgical resection in patients with hepatocelular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization. Ann Surg Oncol. 2007 [citado 23 Jul 2011];14(12).

18. Ríos Zambudio A, Sánchez Bueno F, García Marcilla JA, Robles Campos R, Tamayo Rodríguez ME, Balsalobre Salmerón MD, et al. Factores pronósticos del cáncer de vesícula biliar. Gastroenterol Hepatol. 2001; 24(6):281-6.